
Above Wellness
The U.S. Department of Health and Human Services has announced a new policy addressing six compounded peptides: BPC-157, TB-500, KPV, MOTS-C, Epitalon, and Semax. Learn what the update means for 503A compounding pharmacies, provider-guided peptide therapy, and patients exploring personalized wellness options through Above Wellness.








